scispace - formally typeset
P

Pedro A. Perez-Mancera

Researcher at Cancer Research UK

Publications -  7
Citations -  2967

Pedro A. Perez-Mancera is an academic researcher from Cancer Research UK. The author has contributed to research in topics: Pancreatic cancer & KRAS. The author has an hindex of 3, co-authored 4 publications receiving 2660 citations. Previous affiliations of Pedro A. Perez-Mancera include University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin, +140 more
- 15 Nov 2012 - 
TL;DR: It is found that frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, are also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement ofAxon guidance genes in pancreatic carcinogenesis.
Book ChapterDOI

Physiological analysis of oncogenic K-ras.

TL;DR: Interestingly, it has been observed that supraphysiological expression of oncogenic Ras causes premature senescence, while endogenous expression of the endogenous Kras allele confers immortalization in primary murine cells, suggesting that the predominant biological systems previously used to evaluate onCogenic Ras may not reflect the true molecular or cellular properties of this oncogene.
Journal ArticleDOI

The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis

TL;DR: In this article , the role of miRNAs in the activation of CAFs during the progression of PDAC and its response to therapy, as well as the potential role that PDAC-derived exosomal miRNA may play in activation of hepatic stellate cells (HSCs) and formation of liver metastasis.

4$3*#fyqsfttjpojtefsfhvmbufejoivnbo qsptubufdbodfsboejutefgjdjfodzjonjdf qspnpuftqsptubufofpqmbtjb

TL;DR: It is reported that Scrib is indispensable for prostate homeostasis in mice and the observation that SCRIB deregulation strongly correlated with poor survival in human prostate cancer is suggested, suggesting that the polarity network could provide a new avenue for therapeutic intervention.